Vision cells, not brain, to blame for colour blindness

September 21, 2012, University of Sydney

The real culprits of colour blindness are vision cells rather than unusual wiring in the eye and brain, recent research has shown.

The discovery brings scientists a step closer to restoring full for people who are colour blind – a condition that affects close to two million Australians, says Professor Paul Martin from The and The University of Sydney.

It may also help pave the way for an answer to one of the most common causes of blindness – age-related macular degeneration (AMD), which accounts for half of the cases in Australia.

"There are millions of cones in our eyes – vision cells that pick up bright light and allow us to see colour," Prof. Martin says. "They are nicknamed red, green and blue cones because they are sensitive to different .

"We now know that in the macular region of the eye, each cone has its own 'private line' into the and the brain. Just as a painter can mix from three tubes of paint to produce a wide and vivid palette, our brain uses the 'private lines' from the three cone types to create thousands of colour sensations.

Scientists previously thought that full colour vision depends on specialised nerve wiring in the eye and brain, but animal studies show that the wiring is identical for monkeys whether they have normal or abnormal colour vision, Prof. Martin says.

"This tells us that there's nothing wrong in the brain – it's only working with the signals that it receives on the 'private lines'," he says. "So the only difference in normal and abnormal colour vision is caused by the first stage of sight, which points to faulty cones. Either they have failed to develop, or else they are picking up abnormal wavelengths.

"Now that we know faulty wiring isn't the cause, we can concentrate on fixing the cones, which are controlled by genes – and thus prone to mutation or mistakes during . There are already promising results from gene therapy as a way to restore full colour vision in colour blind monkeys."

"While we have still have some way to go, the benefits of this gene therapy – if successful – can potentially extend beyond providing complete colour vision," he says.

"If we can get these genes to work in human eyes, it means that the same approach might be possible for other visual problems – including blinding diseases such as macular degeneration."

"In macular degeneration, energy supplies to the macula can't keep up with demand. So the 'private line' system must be very energy-intensive. Gene therapy could be used to turn down the cones' energy demand, or to increase energy supply from supporting cells to cone cells," Prof. Martin says.

"Together with clinical researchers at the Save Sight Institute, we are now working hard to find out exactly how many 'private lines' there are in humans. That can point us to where energy demand is highest and we can target to the right place.

"So animal research on 'private lines' for colour has given new clues for understanding one of the most important visual diseases – macular degeneration – in humans."

Explore further: Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained

Related Stories

Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained

August 31, 2011
A new research report published in The FASEB Journal will help ophthalmologists and scientists better understand a rare genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.